RxDoctor Payments Data

Rebecca Sanders, MD

Interventional Pain Medicine · Joplin, MONPI 1265727572

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $159,680 of the $209,337 with a category attached, or 76.3%. 16 manufacturers reported payments, led by Vertos Medical, Inc. at 41.4% of the total. 2025 is the largest year on record at $87,582, more than ten times the $5,275 reported in 2019. Among interventional pain medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$209,337in general payments, 2019–2025

Across 357 payments — averaging $586.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertos Medical, Inc.$87K
  • Stryker$59K
  • MML US, Inc.$56K
  • Abbott$4K
  • Vertiflex, Inc.$2K
  • Medtronic$1K
  • plus $1K from 10 others
$117,796in research payments, 2019–2025

Across 26 payments — averaging $4530.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • MML US, Inc.$118K

What the payments were for

  • Consulting fees$159,68076%
  • Speaking & faculty fees$23,33811%
  • Travel & lodging$18,3859%
  • Food & beverage$7,9344%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$209,337 in reported general payments places this provider in the 95th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$343,996
Medicare patients
776
Services billed
2,877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin91$1,442
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$738
Duloxetine Hcl34$296
Gabapentin11$93
Diazepam13$16

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →